Physician profile
Parveen Gaba
NPI 1386876324
$1,035.88
in general payments reported to CMS, 2019-2025
10 companies · $34.41 in 2025
The $34.41 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $452 · 2023: $193 · 2024: $356 · 2025: $34.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $246.69 | 2022 | |
| Gilead Sciences, INC. | $228.70 | 2024-2025 | Biktarvy, Descovy |
| Viiv Healthcare Company | $211.29 | 2022-2024 | Dovato, Rukobia |
| Merck Sharp & Dohme LLC | $99.35 | 2022-2024 | Zerbaxa, Dificid, Recarbrio |
| Theratechnologies INC. | $93.67 | 2023-2024 | Trogarzo, Egrifta, Egrifta Sv |
| Melinta Therapeutics, LLC | $59.78 | 2023-2024 | Rezzayo, Vabomere |
| La Jolla Pharmaceutical Company | $39.81 | 2023-2024 | Xerava, Xacduro |
| Shionogi INC | $21.37 | 2022 | |
| Aimmune Therapeutics, INC. | $18.41 | 2025 | Vowst |
| Angiodynamics, INC. | $16.81 | 2023 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parveen Gaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.